Ravi Patel MD
Associate Clinical Professor, Oncology, David Geffen School of Medicine at UCLA
Join to View Full Profile
6501 Truxtun AveBakersfield, CA 93309
Phone+1 661-322-2206
Fax+1 661-327-7027
Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1985
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 1980 - 1983
Government Medical College GujuratClass of 1978
Certifications & Licensure
CA State Medical License 1985 - 2027
IL State Medical License 1981 - 1987
IN State Medical License 1984 - 1986
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACP) American College of Physicians, 1995
Clinical Trials
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
- Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors Start of enrollment: 2013 Mar 29
- Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer Start of enrollment: 2014 May 01
- Join now to see all
Publications & Presentations
PubMed
- 40 citationsPathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07).Sara A. Hurvitz, Jennifer L. Caswell-Jin, Katherine McNamara, Jason J. Zoeller, Gregory R. Bean
Nature Communications. 2020-11-17 - 100 citationsOverall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2- ad...Richard S. Finn, Katalin Boér, Igor Bondarenko, Ravindranath Patel, Tamás Pintér
Breast Cancer Research and Treatment. 2020-07-18 - 67 citationsA randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancerZishuo Ian Hu, Johanna C. Bendell, Andrea J. Bullock, Noelle K. LoConte, Hassan Hatoum
Cancer Medicine. 2019-09-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
